摘要
目的探讨检验指标在肝硬化疾病诊断中的临床应用价值。方法整群选取2015年4月—2016年4月该院收治的肝硬化患者62例(观察组)、62名健康人群(对照组),采用速率法检测AST、ALT、r-GT、ALP、CHE,对比分析两组生化检验检出结果。结果观察组AST(100.7±55.1)、ALT(58.6±9.8)、r-GT(175.0±19.3)、ALP(190.6±21.7)明显高于对照组,CHE(2409.3±673.1)、TP(55.7±6.2)、ALB(20.5±1.9)以及纤维蛋白原(1.82±0.58)、血小板(0.06±0.02)明显低于对照组,观察组Ⅲ型前胶原蛋白(289±32.1)、血清透明质酸(513.7±33.6)、层粘连蛋白(326±68.4)、Ⅳ型胶原蛋白(280.5±24.9)四项纤维化指标以及凝血酶时间(18.1±2.0)均明显高于对照组,差异均有统计学意义(P<0.05)。结论临床上可根据检验指标来判断肝脏病变程度。
[Abstrct] Objective To investigate the clinical value of biochemical tests in the diagnosis of liver cirrhosis. Methods Group selection the Biochemical test results of 62 cases (observation group) and 62 healthy people (control group) in our hospital from April 2015 to April 2016,analyse AST、ALT、r-GT、ALP、CHE. Results AST (100.±55.1),ALT (58.6±9.8),r-GT (175.0±19.3),ALP (190.6±21.7)of observation group was higher than the control group, CHE (2409.3±673.1),TP (55.7±6.2 ), ALB(20.5±1.9) was lower than the control group. type III procollagen (289±32.1), serum transparent qualitative acid (51.37± 33.6), laminin (326±68.4), type IV collagen (280.5±24.9) four fibrosis and thrombin time (18.1±2.0) were higher than control group, the differences were statistically meter significance (P〈0.05). Conclusion To judge the degree of liver pathological changes According to the biochemical test index.
出处
《中外医疗》
2016年第20期26-27,共2页
China & Foreign Medical Treatment
关键词
肝硬化
诊断
生化检验指标
Liver cirrhosis
Diagnosis
Biochemical test index